SAN DIEGO, CA--(Marketwire -04/25/12)- Medistem Inc. (MEDS.PK - News) announced Dr. Gene Ray, founder of $2.6 Billion Titan Corp, has invested in and joined the Advisory Board for Medistem Inc. Dr. Ray is a Ph.D in Theoretical Physics, Inventor, and Entrepreneur who founded and sold Titan Corp for $2.6 Billion. Dr. Ray has a long track record of success in … [Read more...]
Gene Ray, Founder of $2.6 Billion Titan Corp, Invests in Medistem’s ERC Technology and Joins Advisory Board
April 25, 2012 By Leave a Comment
Medistem Industry/Academia Collaboration Leads to Nanotechnology Based “Cancer Vaccine”
April 13, 2012 By Leave a Comment
Peer-Reviewed Publication Demonstrates New Method of Treating Prostate Cancer Based on Nanoparticle-Loaded Dendritic Cells SAN DIEGO, CA, Apr 13, 2012 (MARKETWIRE via COMTEX) -- Medistem Inc. (pinksheets:MEDS) announced today it has co-authored a peer-reviewed publication disclosing a new approach to stimulating the immune system to kill tumor cells using a … [Read more...]
Entest BioMedical Excited With Progress on 10 Dog Pilot Study of “Universal Donor” Stem Cell Treatment for Canine Osteoarthritis
March 21, 2012 By Leave a Comment
SAN DIEGO, CA--(Marketwire -03/21/12)- Entest BioMedical Inc. (OTCQB: ENTB.PK - News) (Pinksheets: ENTB.PK - News) Entest's McDonald Animal Hospital has treated 8 dogs in 10 Dog Pilot Study. All of which are showing positive results to the Stem Cell therapy. Osteoarthritis impacts up to 30% of all dogs Entest BioMedical Inc. (OTCQB: ENTB.PK - News) … [Read more...]
Medistem Shareholder Update: March 2012
March 20, 2012 By Leave a Comment
SAN DIEGO, CA--(Marketwire -03/20/12)- Medistem Inc. (Pinksheets: MEDS.PK - News) today issues the following letter to shareholders. Dear Fellow Shareholder: Since our last update in December 2011, we would like to comment on several important developments that have occurred and recap their implications on the successful execution of our business … [Read more...]
Medistem Signs Exclusive Worldwide License With Yale University for Treatment of Type 1 Diabetes Using Stem Cells
March 7, 2012 By Leave a Comment
SAN DIEGO, CA--(Marketwire -03/07/12)- Medistem Inc. (Pinksheets: MEDS.PK - News) and Yale University have signed an exclusive worldwide licensing agreement covering the generation of pancreatic islets from stem cells such as the Endometrial Regenerative Cell (ERC). These pancreatic islets have effectively treated diabetes in animal models. Professor Hugh … [Read more...]
Medistem Inc. to Add Kidney and Lung Failure to Clinical Trials of Endometrial Regenerative Cells (ERC) Stem Cells in Russia
March 5, 2012 By 2 Comments
SAN DIEGO, CA and PORTLAND, OR--(Marketwire -03/05/12)- Medistem Inc. (Pinksheets: MEDS.PK - News), in partnership with its Russian licensee, ERCell, announced the signing of a letter of intent* to begin clinical trials using Medistem's Endometrial Regenerative Cells (ERC) stem cells for renal, lung and peripheral artery disease. Trials will be conducted in the … [Read more...]
Stem Cell Pioneers Converge in Portland to Discuss and Celebrate a Revolutionary New Stem Cell Entering Human Clinical Trials
February 28, 2012 By 1 Comment
An Evening With Medistem, Inc. SAN DIEGO, CA and PORTLAND, OR--(Marketwire -02/28/12)- Medistem Inc. (Pinksheets: MEDS.PK - News) announced today its Annual "Evening with Medistem" Event will take place in Portland, Oregon on March 7th, 2012. The event is being hosted by Vladimir Zaharchook, Vice Chairman at Medistem, Inc., and will feature stem cell … [Read more...]
Medistem Initiates Collaboration With Chinese Conglomerate Aimed at Clinical Development of Endometrial Regenerative Cells for Critical Limb Ischemia
February 18, 2012 By 1 Comment
Shanghai Jia Fu Medical Apparatus Inc to Support Research in "Universal Donor" Stem Cell Drug SAN DIEGO, CA--(Marketwire -02/18/12)- Medistem Inc. (Pinksheets: MEDS.PK - News) announced today initiation of joint efforts with the Chinese conglomerate, Shanghai Jia Fu Medical Apparatus Inc, in developing the Endometrial Regenerative Cell (ERC) "universal donor" … [Read more...]
Benitec Biopharma and Medistem Technologies Successfully Combined in Preclinical Stem Cell Therapy for Rheumatoid Arthritis
February 8, 2012 By 1 Comment
SYDNEY, AUSTRALIA and SAN DIEGO, CA--(Marketwire -02/06/12)- Benitec Biopharma (ASX: BLT.AX - News) and Medistem (Pinksheets: MEDS.PK - News) announced today the successful treatment of rheumatoid arthritis in preclinical models using Benitec Biopharma's patented gene silencing technology applied to stem cell-derived immune system cells called dendritic cells. … [Read more...]
Medistem and ERCell Initiate Phase II RECOVER-ERC Heart Failure Trial
January 30, 2012 By Leave a Comment
First Three Patients Successfully Treated With ERC Stem Cell Using Novel "Retrograde Procedure" SAN DIEGO, CA--(Marketwire -01/30/12)- Medistem Inc. (Pinksheets: MEDS.PK - News) together with its Russian Licensee, ERCell LLC, announced successful dosing of 3 heart failure patients in the Non-Revascularizable IschEmic Cardiomyopathy treated with Retrograde … [Read more...]